Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A sensitive method to assay blood complement C1- inhibitor activity.

C Drouet1, C Alibeu, D Ponard

  • 1Laboratoire d'Immunologie, Hôpital Sud, CHU Grenoble, Echirolles, France.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|May 31, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Homogeneity assessment of the SuperCam calibration targets onboard rover perseverance.

Analytica chimica acta·2022
Same author

Reduced acquisition time for thallium myocardial perfusion imaging with large field cadmium-zinc-telluride SPECT/CT cameras: An equivalence study.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2021
Same author

SuperCam Calibration Targets: Design and Development.

Space science reviews·2020
Same author

Adult moyamoya angiopathy in Bourgogne-Franche-Comté: Epidemiology, diagnosis and management.

Revue neurologique·2018
Same author

Moya-Moya syndrome after cranial radiation for optic glioma with NF1. Case report and literature review of syndromic cases.

Neuro-Chirurgie·2018
Same author

Infections Revealing Complement Deficiency in Adults: A French Nationwide Study Enrolling 41 Patients.

Medicine·2016
Same journal

Micro- and nanoplastics as emerging clinical analytes: analytical validation, interpretive uncertainty, and laboratory actionability in human specimens.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Performance of Free Light Chain reagents in the Dutch External Quality Assessment programme over the past 14 years.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

CRISPR-Cas12a-based liquid biopsy technology: challenges in large-scale clinical application.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Diagnostic biomarkers, prognostic signatures, and therapeutic resistance: shedding light on the dual role of autophagy in glioblastoma.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Artificial intelligence in diagnostic software: validation, safety, and lifecycle challenges in Europe.

Clinica chimica acta; international journal of clinical chemistry·2026
Same journal

Strategies for effective occurrence Management in Resource-Limited Clinical Laboratories: Challenges and practical solutions.

Clinica chimica acta; international journal of clinical chemistry·2026
See all related articles

Hereditary angioneurotic edema is caused by low C1-inhibitor levels. A new spectrophotometric assay accurately quantifies C1-inhibitor functional activity in patient plasma, aiding in diagnosis.

Area of Science:

  • Immunology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Hereditary angioneurotic edema (HAE) is a rare genetic disorder.
  • It is characterized by recurrent episodes of severe swelling.
  • HAE is primarily caused by a deficiency in the complement protein C1-inhibitor (C1-INH).

Purpose of the Study:

  • To develop and validate a routine spectrophotometric assay for quantifying C1-inhibitor functional activity.
  • To establish a reliable method for diagnosing and differentiating types of HAE.
  • To assess C1-inhibitor levels in healthy individuals and HAE patients.

Main Methods:

  • A new spectrophotometric assay utilizing N-alpha-benzoyl-L-arginine ethyl ester was developed.
  • C1-inhibitor activity was measured by the residual esterase activity of C1-s after incubation with patient plasma.

Related Experiment Videos

  • Assay performance was evaluated using EDTA-treated plasma samples from healthy individuals and HAE patients.

    • Main Results:

    • The assay reliably quantifies low C1-inhibitor functional activities, down to 2,000 U/l.
    • Normal C1-inhibitor activity in healthy individuals was estimated at 22,500 +/- 5,000 U/l.
    • A strong correlation (r=0.91) was observed between C1-inhibitor activity and antigen levels.

    Conclusions:

    • The developed assay provides a routinely available method for assessing C1-inhibitor functional activity.
    • Accurate quantification of C1-inhibitor activity is crucial for distinguishing between Type I and Type II HAE.
    • This assay can aid in the diagnosis and management of hereditary angioneurotic edema.